CVS Issues $1.25 Billion of 10-Year Debt to Fund Tender Offer

CVS Caremark Corp. (CVS), the largest provider of prescription drugs in the U.S., sold $1.25 billion of 10-year bonds to repurchase outstanding debt.

CVS issued 2.75 percent notes maturing in 2022 to yield 110 basis points more than similar-maturity Treasuries, according to data compiled by Bloomberg.

The pharmacy services firm announced a tender offer today for any and all of its $1 billion of 6.6 percent debt maturing in March 2019, and as much as $1 billion of its $2.45 billion of bonds maturing in 2016 and 2017, less the aggregate principal amount of 2019 notes tendered and accepted for purchase, according to a statement distributed by PR Newswire.

The pharmacy’s $700 million of 6.125 percent debt maturing in 2016 traded at 118.4 cents on the dollar to yield 1.07 percent on Nov. 23, according to Trace, the bond-price reporting system of the Financial Industry Regulatory Authority.

Barclays Plc and Wells Fargo & Co. managed the sale of the new bonds for the Woonsocket, Rhode Island-based company.

To contact the reporter on this story: Peter Rawlings in New York at prawlings@bloomberg.net

To contact the editor responsible for this story: Alan Goldstein at agoldstein5@bloomberg.net

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.